Myocardial T2* measurement in iron-overloaded Thalassemia: An ex vivo study to investigate optimal methods of quantification

Magnetic Resonance in Medicine

Volumn 60, Issue 2, 2008, Pages 350-356

  He, Taigang ^a,b,c   Gatehouse, Peter D ^b   Kirk, Paul ^a,b   Mohiaddin, Raad H ^a,b   Pennell, Dudley J ^a,b   Firmin, David N ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b Royal Brampton Hospital   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Curve fitting; Ex vivo heart; Iron overload; MRI; Noise; T2* relaxation

Indexed keywords

CURVE FITTING; HEART; IRON; MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT;

CARDIAC COMPLICATIONS; CURVE FITTING MODEL; EX-VIVO; IRON OVERLOADS; MONOEXPONENTIAL MODELS; NOISE; NONLINEAR ALGORITHMS; NONLINEAR CURVE FITTING;

SIGNAL TO NOISE RATIO;

ALGORITHM; ARTICLE; BETA THALASSEMIA; DIAGNOSTIC ACCURACY; EX VIVO STUDY; HEART; HUMAN; HUMAN TISSUE; IRON OVERLOAD; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; SIGNAL NOISE RATIO; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; EVALUATION; HEART MUSCLE; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SENSITIVITY AND SPECIFICITY; THALASSEMIA;

IRON;

ALGORITHMS; DIAGNOSIS, COMPUTER-ASSISTED; HUMANS; IRON; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MYOCARDIUM; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THALASSEMIA;

EID: 49049106515     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21625     Document Type: Article

References (30)

1. Tanner MA, Porter JB, Westwood MA, Nair SV, Anderson LJ, Walker JM, Penneil DJ. Myocardial T2* in patients with cardiac failure secondary to iron overload (abstract). Blood 2005;106(suppl):3838a.
2. Tanner MA, Galanello R, Dessi C, Westwood MA, Smith GC, Nair SV, Anderson LJ, Walker JM, Pennell DJ. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006;8:543-547.
3. Pennell DJ. T2* Magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci 2005;1054:373-378.
4. Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Smith GC, Westwood MA, Wonke B, Galanello R. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 2006;107:3738-3744.
5. Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Roughton M, Assomull R, Nair SV, Walker JM, Pennell DJ. A randomized, placebo controlled, double blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 2007;115:1876-1884.
6. Anderson LJ, Holden S, Davies B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179.
7. Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, Pennell DJ. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003;18:33-39.
8. Westwood MA, Anderson LJ, Firmin DN, Gatehouse PD, Lorenz CH, Wonke B, Pennell DJ. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging 2003;18:616-620.
9. Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TD. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004;103:1934-1936.
10. Wood JC, Otto-Duessel M, Aguilar M, Nick H, Nelson MD, Coates TD, Pollack H, Moats R. Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005;112:535-543.
11. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron levels and ventricular function in beta thalassemia. Lancet 2002;360:516-520.
12. Anderson LJ, Westwood MA, Holden S, Davis B, Prescott E, Wonke B, Porter JB, Walker JM, Pennell DJ. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: A prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 2004;127:348-355.
13. Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Smith GC, Westwood MA, Wonke B, Galanello R. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 2006;107:3738-3744.
14. Anderson LJ, Westwood MA, Prescott E, Walker JM, Pennell DJ, Wonke B. Development of thalassaemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine. Acta Haematol 2006;115:106-108.
15. Pepe A, Lombardi M, Positano V, Cracolici E, Capra M, Malizia R, Prossomariti L, De Marchi D, Midiri M, Maggio A. Evaluation of the efficacy of oral deferiprone in beta-thalassemia major by multislice multiecho T2*. Eur J Haematol 2006;76:183-192.
16. Pepe A, Positano V, Santarelli MF, Sorrentino F, Cracolici E, De Marchi D, Maggio A, Midiri M, Landini L, Lombardi M. Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload. J Magn Reson Imaging 2006;23:662-668.
17. He T, Tanner MA, Kirk P, Gatehouse PD, Pennell DJ, Firmin DN. Optimization of a multiecho T2* technique for the measurement of myocardial iron overload. J Cardiovasc Magn Reson 2006;8:45-47 (abstract 149).
18. Ghugre NR, Enriquez CM, Coates TD, Nelson MD, Wood JC. Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging 2006;23:9-16.
19. Ghugre NR, Enriquez CM, Gonzalez I, Nelson MD Jr, Coates TD, Wood JC. MRI detects myocardial iron in the human heart. Magn Reson Med. 2006;56(3):681-686.
20. St Pierre TG, Clark PR, Chua-Anusorn W. Single spin-echo proton transverse relaxometry of iron-loaded liver. NMR Biomed 2004;17:446-458.
21. Yousem DM, Ihmeida I, Quencer R, Atlas SW. Paradoxically decreased signal intensity on post contrast short-TR MR images. AJNR 1991;12:875-880.
22. Haacke EM, Brown RW, Thompson MR, Venkatesan R. Magnetic resonance imaging: physical principles and sequence design. New York: Wiley-Liss; 1999:914.
23. Henkelman RM. Measurement of signal intensities in the presence of noise in MR images. Med Phys 1985;12:232-233.
24. Gudbjartsson H, Patz S. The Rician distribution of noisy MRI data. Magn Reson Med 1995;34:910-914.
25. Constantinides CD, Atalar E, McVeigh ER. Signal-to-noise measurements in magnitude images from NMR phased arrays. Magn Reson Med 1997;38:852-857.
26. Miller AJ, Joseph PM. The use of power images to perform quantitative analysis on low SNR MR images. Magn Reson Imaging 1993;11:1051-1056.
27. Roemer PB, Edelstein WA, Hayes CE, Souza SP, Mueller OM. The NMR phased array. Magn Reson Med 1990;16:192-225.
28. Marqurdt D. An algorithm for least squares estimation of non-linear parameters. J Soc Ind Appl Math 1963;431-434.
29. Press W, Teukolsky S, Vetterling W, Flannery B. Numerical recipes in C: the art of scientific computing, 2nd ed. Cambridge University Press: New York, 1992.
30. Bonny JM, Zanca M, Boire JY, Veyre A. T2 maximum likelihood estimation from multiple spin-echo magnitude images. Magn Reson Med 1996;36:287-293.